Breathe Well Live Well
Condition: Asthma
Interventions: Drug: PBF-680; Drug: Placebo
Sponsors: Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau; Palo Biofarma, S.L
Recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Biological: Trophic factors from umbilical cord mesenchymal stem cells
Sponsor: Translational Biosciences
Recruiting – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Uncontrolled Asthma
Interventions: Biological: Tralokinumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Berodual® Respimat®, low dose; Drug: Berodual® Respimat®, high dose; Drug: Berodual® MDI
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Drug: salbutamol sulfate + ipratropium bromide
Sponsor: Boehringer Ingelheim
Terminated – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Persistent Asthma
Interventions: Drug: Fluticasone propionate Multidose Dry Powder Inhaler (Fp MDPI); Drug: Fluticasone propionate /salmeterol MDPI (FS MDPI); Drug: Fluticasone propionate HFA Inhalation Aerosol; Drug: Fluticasone propionate/salmeterol dry powder formulation
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Respimat® Budesonide low dose; Drug: Respimat® Budesonide high dose; Drug: Turbohaler® Budesonide; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Biological: Mepolizumab
Sponsor: GlaxoSmithKline
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol; Drug: mometasone furoate and formoterol
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: NVA237; Drug: Placebo to NVA237; Drug: salbutamol/ albuterol
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days